BIG
CORT icon

Brooklyn Investment Group’s Corcept Therapeutics CORT Stock Holding History

Brooklyn Investment Group’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,475
Closed -$254K – 1509
2025
Q3 		$254K Sell
3,475
-1,234
-26% -$89.3K 0.03% 486
2025
Q2 		$346K Buy
4,709
+4,336
+1,162% +$314K 0.05% 394
2025
Q1 		$42.6K Buy
373
+186
+99% +$11.3K 0.01% 851
2024
Q4 		$9.42K Buy
+187
New +$9.8K ﹤0.01% 1005

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brooklyn Investment Group's CORT Position: Q4 2025 in Review

Brooklyn Investment Group sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 3,475 shares — an estimated $254K sold.

Brooklyn Investment Group first reported a position in CORT in Q4 2024 and held it in 4 quarters. The position peaked at $346K in Q2 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • Brooklyn Investment Group reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 3,475 Corcept Therapeutics shares in Q4 2025, an estimated $254K.
  • Brooklyn Investment Group first reported a position in Corcept Therapeutics in Q4 2024 and held it in 4 quarters.
  • Brooklyn Investment Group's Corcept Therapeutics position peaked at $346K in Q2 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on Brooklyn Investment Group's 13F filing for Q4 2025, filed 12 Feb 2026.